PFAS Risks In M&A Amid Litigation, Legislative Developments
By Stuart Hammer, Harry Zirlin and Avery Bashe · March 5, 2026, 4:11 PM EST
In mergers and acquisitions, risks relating to per- and polyfluoroalkyl substances, or PFAS, have become a significant concern for many buyers. This situation stems largely from the multibillion-dollar settlements for PFAS...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login